← Insiders

NGL

ACHAT TOTAL: 26626 titres (~432002 USD)

Insiders
RAYMOND JOHN T
Total bought
$432,002
Total sold
Last activity
2026-08-24
Last synced
2026-08-26 03:23:35 Synced via automated research pipeline

Insider holdings as a share of total assets aren't available for this company.

Price (1 year)

Live chart from TradingView - pulls its own market data, independent of this site's database. Symbol resolution is best-effort (defaults to NASDAQ) since we don't store the exchange prefix.

Market snapshot

Signal

Neutral signal Scored 2026-09-06

NGL presents a compelling near-term earnings catalyst — Q1 FY2027 beat, raised EBITDA guidance to $725M+, and meaningful insider buying — but these positive signals are severely undermined by critically deteriorated…

The first sentence of the analysis written for NGL on 2026-09-06 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.

Financial ratios

MetricTrend2026-03-312025-03-312024-03-312023-03-312022-03-31
Gross Profit Margin23.7%20.4%16.9%12.6%6.5%
Ebit Margin2.4%9.4%2.4%4.7%0.9%
Ebitda Margin10.7%17.2%9.2%9.8%4.8%
Operating Profit Margin12.2%9.5%3.9%4.3%1.0%
Pretax Profit Margin-5.7%1.7%-3.8%0.2%-2.3%
Continuous Operations Profit Margin-5.7%1.9%-3.8%0.2%-2.3%
Net Profit Margin-5.7%1.1%-3.5%0.9%-2.3%
Bottom Line Profit Margin-14.1%-2.3%-6.8%-1.3%-3.6%
Current Ratio1.0471.3011.2081.1641.211
Quick Ratio0.9561.2071.0991.0361.014
Solvency Ratio0.0190.0780.0340.0830.025
Cash Ratio0.0120.0080.0400.0050.003
Price To Earnings Ratio-3.533-7.567-2.710-5.179-1.000
Price To Earnings Growth Ratio-0.0070.105-0.0100.0690.016
Forward Price To Earnings Growth Ratio-0.0070.105-0.0100.0690.016
Price To Earnings Diluted Ratio-3.533-7.567-2.710-5.179-1.000
Price To Earnings Diluted Growth Ratio-0.0070.105-0.0100.0690.016
Price To Book Ratio60.4530.8860.7410.2800.222
Price To Sales Ratio0.4960.1730.1850.0670.036
Price To Free Cash Flow Ratio10.82511.60514.8401.2774.540
Price To Operating Cash Flow Ratio4.2802.0152.5770.8531.400
Debt To Assets Ratio0.8040.6690.5910.5410.571
Debt To Equity Ratio129.5954.5572.8692.1782.666
Debt To Capital Ratio0.9920.8200.7420.6850.727
Long Term Debt To Capital Ratio0.9920.8140.7330.6780.720
Financial Leverage Ratio161.1746.8124.8564.0284.667
Working Capital Turnover Ratio24.53416.28221.54125.15943.411
Operating Cash Flow Ratio0.4950.4020.3040.4010.161
Operating Cash Flow Sales Ratio0.1160.0860.0720.0780.026
Free Cash Flow Operating Cash Flow Ratio0.3950.1740.1740.6680.308
Debt Service Coverage Ratio1.1272.0771.3021.9051.466
Interest Coverage Ratio1.5131.1760.6360.9430.326
Short Term Operating Cash Flow Coverage Ratio8.14733.7838.17513.03086.563
Operating Cash Flow Coverage Ratio0.1090.0960.1000.1510.059
Capital Expenditure Coverage Ratio1.6541.2101.2103.0131.446
Dividend Paid And Capex Coverage Ratio1.0930.5400.5403.0131.446
Dividend Payout Ratio-0.6307.755-2.1240.0000.000
Enterprise Value Multiple14.5916.1819.7085.9589.930

Sparkline shows each ratio oldest → newest (left → right).

How the latest year compares

For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. higher lower

MetricCurrentvs 1Y agovs 5Y avg
Gross Profit Margin 23.7% 3.3% 7.6%
Ebit Margin 2.4% -7.1% -1.6%
Ebitda Margin 10.7% -6.5% 0.4%
Operating Profit Margin 12.2% 2.7% 6.0%
Pretax Profit Margin -5.7% -7.4% -3.7%
Continuous Operations Profit Margin -5.7% -7.5% -3.7%
Net Profit Margin -5.7% -6.8% -3.8%
Bottom Line Profit Margin -14.1% -11.8% -8.5%
Current Ratio 1.047 -0.255 -0.140
Quick Ratio 0.956 -0.251 -0.107
Solvency Ratio 0.019 -0.059 -0.029
Cash Ratio 0.011 0.004 -0.002
Price To Earnings Ratio -3.533 4.034 0.465
Price To Earnings Growth Ratio -0.007 -0.113 -0.042
Forward Price To Earnings Growth Ratio -0.007 -0.113 -0.042
Price To Earnings Diluted Ratio -3.533 4.034 0.465
Price To Earnings Diluted Growth Ratio -0.007 -0.113 -0.042
Price To Book Ratio 60.453 59.568 47.937
Price To Sales Ratio 0.496 0.324 0.305
Price To Free Cash Flow Ratio 10.825 -0.779 2.208
Price To Operating Cash Flow Ratio 4.280 2.265 2.055
Debt To Assets Ratio 0.804 0.135 0.169
Debt To Equity Ratio 129.595 125.037 101.222
Debt To Capital Ratio 0.992 0.172 0.199
Long Term Debt To Capital Ratio 0.992 0.178 0.204
Financial Leverage Ratio 161.174 154.363 124.867
Working Capital Turnover Ratio 24.534 8.251 -1.652
Operating Cash Flow Ratio 0.495 0.092 0.142
Operating Cash Flow Sales Ratio 0.116 0.030 0.040
Free Cash Flow Operating Cash Flow Ratio 0.395 0.222 0.051
Debt Service Coverage Ratio 1.127 -0.949 -0.448
Interest Coverage Ratio 1.512 0.337 0.594
Short Term Operating Cash Flow Coverage Ratio 8.148 -25.636 -21.792
Operating Cash Flow Coverage Ratio 0.109 0.013 0.006
Capital Expenditure Coverage Ratio 1.654 0.444 -0.053
Dividend Paid And Capex Coverage Ratio 1.093 0.553 -0.233
Dividend Payout Ratio -0.630 -8.385 -1.630
Enterprise Value Multiple 14.591 8.411 5.318

Key metrics

MetricTrend20262025202420232022
Market cap$1.57B$599.3M$766.4M$379.9M$288.2M
Enterprise value$4.92B$3.68B$3.69B$3.32B$3.75B
EV / Sales1.56x1.06x0.89x0.58x0.47x
EV / Op. cash flow13.43x12.36x12.41x7.47x18.22x
EV / Free cash flow33.97x71.20x71.51x11.18x59.09x
EV / EBITDA14.59x6.18x9.71x5.96x9.93x
Net debt / EBITDA9.94x5.17x7.69x5.28x9.17x
Current ratio1.05x1.30x1.21x1.16x1.21x
Income quality-2.63x6.89x6.89x8.48x-1.12x
Graham number$6$10
Graham net-net-$29-$26-$26-$25-$29
Tax burden100.8%65.5%92.0%555.3%100.9%
Interest burden-237.1%18.3%-158.9%3.5%-255.9%
Working capital$34.5M$222.8M$203.3M$182.3M$269.1M
Invested capital$3.40B$3.83B$3.93B$4.25B$4.71B
Return on assets-4.3%0.9%-2.9%0.9%-3.0%
Operating ROA8.8%6.8%3.1%4.2%1.4%
Return on tangible assets-6.0%1.2%-4.1%1.4%-4.4%
Return on equity-695.5%5.8%-13.9%3.8%-14.2%
Return on invested capital11.0%8.4%4.0%5.4%1.7%
Return on capital employed11.2%8.5%4.0%5.6%1.7%
Earnings yield-11.5%6.6%-18.8%13.5%-64.1%
Free cash flow yield9.2%8.6%6.7%78.3%22.0%
Capex / Op. cash flow60.5%82.6%82.6%33.2%69.2%
Capex / Depreciation82.3%92.0%92.0%50.8%46.5%
Capex / Sales7.0%7.1%5.9%2.6%1.8%
SG&A / Sales11.5%1.6%2.9%1.3%0.8%
R&D / Sales0.0%0.0%0.0%0.0%0.0%
Stock comp / Sales0.4%0.0%0.0%0.0%-0.0%
Intangibles / Total assets27.7%31.1%30.5%32.2%30.7%
Days sales outstanding77d61d63d67d52d
Days payables outstanding75d61d68d68d53d
Operating cycle88d71d75d78d64d
Cash conversion cycle13d10d7d10d11d

Change by theme

Grouped by what each metric measures. Each figure is the change over the period shown — up down versus then.

Change over 1 year

Valuation
Market cap ▲+161.3%EV / Sales ▲+46.9%EV / EBITDA ▲+136.1%EV / Op. cash flow ▲+1.068Earnings yield ▼-0.181
Profitability
Return on equity ▼-7.013Return on assets ▼-0.052Return on invested capital ▲+0.026Return on capital employed ▲+0.027Operating ROA ▲+0.019Income quality ▼-9.521Tax burden ▲+0.353
Efficiency
Days sales outstanding ▲+16.067Days payables outstanding ▲+13.960Operating cycle ▲+17.032Cash conversion cycle ▲+3.071Capex / Sales ▼-0.001R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.255Net debt / EBITDA ▲+4.768Working capital ▼-188355000.000Invested capital ▼-436985000.000Intangibles / Total assets ▼-0.034

Change over 5 years

Valuation
Market cap ▲+443.3%EV / Sales ▲+229.9%EV / EBITDA ▲+46.9%EV / Op. cash flow ▼-4.793Earnings yield ▲+0.526
Profitability
Return on equity ▼-6.813Return on assets ▼-0.013Return on invested capital ▲+0.093Return on capital employed ▲+0.095Operating ROA ▲+0.074Income quality ▼-1.512Tax burden ▼-0.001
Efficiency
Days sales outstanding ▲+25.505Days payables outstanding ▲+21.718Operating cycle ▲+23.363Cash conversion cycle ▲+1.645Capex / Sales ▲+0.052R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-0.164Net debt / EBITDA ▲+0.774Working capital ▼-234669000.000Invested capital ▼-1312140000.000Intangibles / Total assets ▼-0.030

Employee count

Peer market caps

Congressional trades

Recent trades

DateRepresentativeTypeAmount
2025-02-28Mark Dr GreenSale (Full)$15,001 - $50,000
2025-02-03Mark Dr GreenSale$250,001 - $500,000
2025-01-30Mark Dr GreenSale$500,001 - $1,000,000
2025-01-28Mark Dr GreenSale$50,001 - $100,000
2025-01-02Mark Dr GreenSale (Full)$15,001 - $50,000
2024-12-03Mark Dr GreenSale (Full)$15,001 - $50,000
2024-10-24Mark Dr GreenSale (Full)$50,001 - $100,000
2024-10-16Mark Dr GreenSale (Full)$50,001 - $100,000
2024-09-30Mark Dr GreenSale (Full)$100,001 - $250,000
2024-09-17Mark Dr GreenSale (Full)$1,001 - $15,000
2024-08-28Mark Dr GreenSale (Full)$50,001 - $100,000
2024-08-05Mark Dr GreenSale (Full)$50,001 - $100,000
2024-07-24Mark Dr GreenSale (Full)$15,001 - $50,000
2024-07-01Mark Dr GreenSale (Full)$50,001 - $100,000
2024-06-03Mark Dr GreenSale (Full)$100,001 - $250,000
2024-05-10Mark Dr GreenSale (Full)$15,001 - $50,000
2024-05-07Mark Dr GreenSale (Full)$250,001 - $500,000
2024-04-25Mark Dr GreenSale (Full)$100,001 - $250,000
2024-04-01Mark Dr GreenSale (Full)$100,001 - $250,000
2024-03-11Mark Dr GreenSale (Full)$15,001 - $50,000
2024-02-26Mark Dr GreenSale (Full)$50,001 - $100,000
2024-01-29Mark Dr GreenSale (Full)$100,001 - $250,000
2024-01-11Mark Dr GreenSale (Full)$100,001 - $250,000
2023-08-04Mark Dr GreenPurchase$250,001 - $500,000
2023-06-08Mark Dr GreenPurchase$100,001 - $250,000
2023-06-02Mark Dr GreenPurchase$100,001 - $250,000
2023-03-24Mark Dr GreenPurchase$100,001 - $250,000
2023-01-03Mark Dr GreenSale (Full)$1,001 - $15,000
2022-08-29Mark Dr GreenSale (Full)$1,001 - $15,000
2022-06-02Mark Dr GreenPurchase$100,001 - $250,000
2022-01-12Mark Dr GreenPurchase$15,001 - $50,000
2022-01-06Mark Dr GreenPurchase$50,001 - $100,000
2021-12-21Mark Dr GreenSale (Full)$15,001 - $50,000
2021-11-17Mark Dr GreenPurchase$15,001 - $50,000
2021-05-20Mark Dr GreenPurchase$1,001 - $15,000
2021-05-06Mark Dr GreenPurchase$1,001 - $15,000
2021-05-05Mark Dr GreenPurchase$1,001 - $15,000
2021-04-21Mark Dr GreenPurchase$1,001 - $15,000
2021-03-17Mark Dr GreenPurchase$15,001 - $50,000
2021-03-12Mark Dr GreenPurchase$50,001 - $100,000
2021-03-04Mark Dr GreenSale (Full)$100,001 - $250,000
2021-02-24Mark Dr GreenSale (Full)$100,001 - $250,000
2021-02-18Mark Dr GreenSale (Full)$100,001 - $250,000
2021-01-19Mark Dr GreenPurchase$15,001 - $50,000
2020-12-01Mark Dr GreenPurchase$15,001 - $50,000
2020-11-24Mark Dr GreenPurchase$15,001 - $50,000
2020-11-18Mark Dr GreenPurchase$15,001 - $50,000
2020-11-17Mark Dr GreenPurchase$15,001 - $50,000
2020-11-13Mark Dr GreenPurchase$15,001 - $50,000
2020-11-10Mark Dr GreenPurchase$15,001 - $50,000
2020-11-09Mark Dr GreenPurchase$15,001 - $50,000
2020-10-16Mark Dr GreenPurchase$1,001 - $15,000
2020-10-15Mark Dr GreenPurchase$100,001 - $250,000
2020-10-05Mark Dr GreenPurchase$1,001 - $15,000
2020-10-05Mark Dr GreenSale (Full)$100,001 - $250,000
2020-09-11Mark Dr GreenPurchase$1,001 - $15,000
2020-08-12Mark Dr GreenPurchase$15,001 - $50,000
2020-08-11Mark Dr GreenPurchase$15,001 - $50,000
2020-08-04Mark Dr GreenPurchase$1,001 - $15,000
2020-07-08Mark Dr GreenPurchase$15,001 - $50,000
2020-07-07Mark Dr GreenPurchase$15,001 - $50,000
2020-07-02Mark Dr GreenPurchase$15,001 - $50,000
2020-06-11Mark Dr GreenPurchase$1,001 - $15,000
2020-06-10Mark Dr GreenPurchase$15,001 - $50,000
2020-06-10Mark Dr GreenPurchase$50,001 - $100,000
2020-02-27Kevin HernSale (Full)$15,001 - $50,000
2020-02-14Kevin HernPurchase$1,001 - $15,000
2019-05-15Kevin HernPurchase$1,001 - $15,000

Recent news